重症加護中心
經濟效益
Restrictive blood transfusion practices are associated with improved patient outcomes. （開啟新視窗）
出處: Transfusion 2014;54(10 Pt 2):2753-9.
檢索: PubMed 24995770
DOI碼: 10.1111/trf.12723
Improved outcomes and reduced costs associated with a health-system-wide patient blood management program: a retrospective observational study in four major adult tertiary-care hospitals. （開啟新視窗）
出處: Transfusion 2017;57(6):1347-58.
檢索: PubMed 28150313
DOI碼: 10.1111/trf.14006
Cost-effectiveness of recombinant human erythropoietin for reducing red blood cells transfusions in critically ill patients. （開啟新視窗）
出處: Value Health 2005;8(2):105-16.
檢索: PubMed 15804319
DOI碼: 10.1111/j.1524-4733.2005.04006.x
Implementation of a patient blood management monitoring and feedback program significantly reduces transfusions and costs. （開啟新視窗）
出處: Transfusion 2015;55(12):2807-15.
檢索: PubMed 26264557
DOI碼: 10.1111/trf.13260
Trauma-induced coagulopathy: impact of the early coagulation support protocol on blood product consumption, mortality and costs. （開啟新視窗）
出處: Crit Care 2015;19:83.
檢索: PubMed 25880548
DOI碼: 10.1186/s13054-015-0817-9
The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients. （開啟新視窗）
出處: Health Technol Assess 2013;17(10):1-79.
檢索: PubMed 23477634
DOI碼: 10.3310/hta17100
Reversal of coagulopathy in critically ill patients with traumatic brain injury: recombinant factor VIIa is more cost-effective than plasma. （開啟新視窗）
出處: J Trauma 2009;66(1):63-72.
檢索: PubMed 19131807
DOI碼: 10.1097/TA.0b013e318191bc8a
Effect of a restrictive transfusion strategy on transfusion-attributable severe acute complications and costs in the US ICUs: a model simulation. （開啟新視窗）
出處: BMC Health Serv Res 2007;7:138.
檢索: PubMed 17764560
DOI碼: 10.1186/1472-6963-7-138